Clinical Trials Directory

Trials / Sponsors / Fondazione Italiana Sindromi Mielodisplastiche-ETS

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Academic / Other · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedEfficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche
Myeloid Dysplasia
—2022-01-01
CompletedPersonalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clini
MDS (Myelodysplastic Syndrome)
—2020-06-03
TerminatedEarly and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissu
Myelodysplastic Syndromes
Phase 22019-10-04
RecruitingItalian Network MDS Registry
Myelodysplastic-Myeloproliferative Diseases
—2013-09-01
CompletedIdentification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation The
Myelodysplasia, Myelofibrosis, Aplastic Anemia
—2013-05-01
CompletedMulticenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Chronic Myelomonocytic Leukemia
Phase 22010-04-01
TerminatedMulticentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy
Myelodysplastic Syndromes
Phase 32007-03-01
TerminatedStudy of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Myelodysplastic Syndromes
Phase 22005-09-01
WithdrawnStudy of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes
Myelodysplastic Syndromes
Phase 2—